Stock FATE FATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Fate Therapeutics, Inc.

Equities

FATE

US31189P1021

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
3.88 USD -8.06% Intraday chart for Fate Therapeutics, Inc. -1.77% +3.74%
Apr. 22 Fate Therapeutics, Inc. Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting CI
Mar. 21 Fate Therapeutics, Inc. announced that it has received $19.996366 million in funding from Redmile Group, LLC CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FATE Stock
  4. News Fate Therapeutics, Inc.
  5. MarketScreener Strategies
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW